Cargando…

The risk of AIDS-defining events is decreasing over time in the German HIV-1 Seroconverter Cohort

BACKGROUND: With ageing of the HIV-infected population, long-term exposure to treatment, varying adherence, emerging resistance and complications to therapies, effectiveness of Highly Active Antiretroviral Therapy (HAART) needs to be monitored continuously at the population level. The German HIV-1 S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Altmann, Mathias, an der Heiden, Matthias, Scheufele, Ramona, Hartmann, Katrin, Houareau, Claudia, Bartmeyer, Barbara, Hamouda, Osamah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494508/ https://www.ncbi.nlm.nih.gov/pubmed/22515400 http://dx.doi.org/10.1186/1471-2334-12-94

Ejemplares similares

Prevalence of Transmitted Drug Resistance and Impact of Transmitted Resistance on Treatment Success in the German HIV-1 Seroconverter Cohort
por: Bartmeyer, Barbara, et al.
Publicado: (2010)

First Line Treatment Response in Patients with Transmitted HIV Drug Resistance and Well Defined Time Point of HIV Infection: Updated Results from the German HIV-1 Seroconverter Study
por: zu Knyphausen, Fabia, et al.
Publicado: (2014)

Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort
por: Machnowska, Patrycja, et al.
Publicado: (2019)

CCR5Δ32 Genotypes in a German HIV-1 Seroconverter Cohort and Report of HIV-1 Infection in a CCR5Δ32 Homozygous Individual
por: Oh, Djin-Ye, et al.
Publicado: (2008)

Improved Testing of Recent HIV-1 Infections with the BioRad Avidity Assay Compared to the Limiting Antigen Avidity Assay and BED Capture Enzyme Immunoassay: Evaluation Using Reference Sample Panels from the German Seroconverter Cohort
por: Hauser, Andrea, et al.
Publicado: (2014)

Tuberculosis among people living with HIV/AIDS in the German ClinSurv HIV Cohort: long-term incidence and risk factors
por: Karo, Basel, et al.
Publicado: (2014)

Everything counts - a method to determine viral suppression among people living with HIV using longitudinal data for the HIV care continuum - results of two large, German, multi-center real-life cohort studies over 20 years (1999–2018)
por: Schmidt, Daniel, et al.
Publicado: (2021)

High Prevalence and High Incidence of Coinfection with Hepatitis B, Hepatitis C, and Syphilis and Low Rate of Effective Vaccination against Hepatitis B in HIV-Positive Men Who Have Sex with Men with Known Date of HIV Seroconversion in Germany
por: Jansen, Klaus, et al.
Publicado: (2015)

HIV-Prevalence in Tuberculosis Patients in Germany, 2002–2009: An Estimation Based on HIV and Tuberculosis Surveillance Data
por: Fiebig, Lena, et al.
Publicado: (2012)

Differences in HIV Natural History among African and Non-African Seroconverters in Europe and Seroconverters in Sub-Saharan Africa
por: Pantazis, Nikos, et al.
Publicado: (2012)

Protective effect of KIR3DS1 in asymptomatic HIV-1 seroconverters towards AIDS
por: Stalinraja, M, et al.
Publicado: (2012)

CD4-cell counts and presence of AIDS in HIV-positive patients entering specialized care—a comparison of migrant groups in the German ClinSurv HIV Cohort Study, 1999–2013
por: Zeitlmann, Nadine, et al.
Publicado: (2016)

Calculation of Direct Antiretroviral Treatment Costs and Potential Cost Savings by Using Generics in the German HIV ClinSurv Cohort
por: Stoll, Matthias, et al.
Publicado: (2011)

Cytokine cascade and networks among MSM HIV seroconverters: implications for early immunotherapy
por: Huang, Xiaojie, et al.
Publicado: (2016)

Upregulation of PTPRC and Interferon Response Pathways in HIV-1 Seroconverters Prior to Infection
por: Li, Yunqi, et al.
Publicado: (2023)

Detection of a Single Identical Cytomegalovirus (CMV) Strain in Recently Seroconverted Young Women
por: Murthy, Suchetha, et al.
Publicado: (2011)

Viral Linkage in HIV-1 Seroconverters and Their Partners in an HIV-1 Prevention Clinical Trial
por: Campbell, Mary S., et al.
Publicado: (2011)

Immune Status and Epidemiological Characteristics of Human Immunodeficiency Virus Seroconverters in Korea, 1999–2009
por: Wang, Jin-Sook, et al.
Publicado: (2012)

An Evaluation of HIV Elite Controller Definitions within a Large Seroconverter Cohort Collaboration
por: Olson, Ashley D., et al.
Publicado: (2014)

Brief Report: Sexual Risk Behaviors of HIV Seroconverters in the US Army, 2012–2014
por: Hakre, Shilpa, et al.
Publicado: (2015)

Risk of Deaths, AIDS-Defining and Non-AIDS Defining Events among Ghanaians on Long-Term Combination Antiretroviral Therapy
por: Sarfo, Fred Stephen, et al.
Publicado: (2014)

Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa
por: Amornkul, Pauli N., et al.
Publicado: (2013)

Whole genome deep sequencing analysis of viral quasispecies diversity and evolution in HBeAg seroconverters
por: Lin, Su-Ru, et al.
Publicado: (2021)

HIV‐1 drug resistance among individuals who seroconverted in the ASPIRE dapivirine ring trial
por: Parikh, Urvi M., et al.
Publicado: (2021)

Das Lagemanagement des Robert Koch-Instituts während der COVID-19-Pandemie und der Austausch zwischen Bund und Ländern
por: Halm, Ariane, et al.
Publicado: (2021)

Seroconverting Blood Donors as a Resource for Characterising and Optimising Recent Infection Testing Algorithms for Incidence Estimation
por: Kassanjee, Reshma, et al.
Publicado: (2011)

Mother to child transmission of HIV among Zimbabwean women who seroconverted postnatally: prospective cohort study
por: Humphrey, Jean H, et al.
Publicado: (2010)

Host Genetic Factors Associated with Symptomatic Primary HIV Infection and Disease Progression among Argentinean Seroconverters
por: Coloccini, Romina Soledad, et al.
Publicado: (2014)

Seroconverting nonresponder of high-dose intramuscular HBV vaccine with intradermal HBV vaccine: A case report
por: Das, Manjusha, et al.
Publicado: (2017)

IFN-α as a time-sensitive biomarker during Oropouche virus infection in early and late seroconverters
por: de Oliveira, Euzébio, et al.
Publicado: (2019)

Increased non‐AIDS mortality among persons with AIDS‐defining events after antiretroviral therapy initiation
por: Pettit, April C, et al.
Publicado: (2018)

Spectrum of AIDS defining & non-AIDS defining malignancies in north India
por: Sachdeva, Ravinder Kaur, et al.
Publicado: (2016)

Disease progression of HIV-1 infection in symptomatic and asymptomatic seroconverters in Osaka, Japan: a retrospective observational study
por: Watanabe, Dai, et al.
Publicado: (2015)

The Impact of HCV Infection Duration on HIV Disease Progression and Response to cART amongst HIV Seroconverters in the UK
por: Inshaw, Jamie, et al.
Publicado: (2015)

Abnormal T Cell Frequencies, Including Cytomegalovirus-Associated Expansions, Distinguish Seroconverted Subjects at Risk for Type 1 Diabetes
por: Harms, Robert Z., et al.
Publicado: (2018)

Characteristics of HIV seroconverters in the setting of universal test and treat: Results from the SEARCH trial in rural Uganda and Kenya
por: Nyabuti, Marilyn N., et al.
Publicado: (2021)

Molecular evolution of HIV-1 integrase during the 20 years prior to the first approval of integrase inhibitors
por: Meixenberger, Karolin, et al.
Publicado: (2017)

German and international studies on SARS-CoV-2 seroprevalence
por: Poethko-Müller, Christina, et al.
Publicado: (2020)

Surveillance of recent HIV infections among newly diagnosed HIV cases in Germany between 2008 and 2014
por: Hofmann, Alexandra, et al.
Publicado: (2017)

Acute retroviral syndrome and high baseline viral load are predictors of rapid HIV progression among untreated Argentinean seroconverters
por: Socías, M Eugenia, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_orgnhfpe8g3ijf05ij8jq7jbm1